What we do Zenlabs Ethica Ltd is a leading Indian pharmaceutical contract marketing company offering over 600 branded drugs across various therapeutic segments including gastrointestinal, anti-diabetics, and nutraceuticals. |
Founded in 1,993 |
Market share Among top 10 pharmaceutical contract marketing and trading companies in India as of 2019. |
Problem solved Provides quality and affordable branded pharmaceutical products to improve health outcomes across multiple therapeutic areas. |
Top clients or who we serve Serves pharmacies and healthcare providers in India through B2B pharmaceutical distribution. |
Key management Mr. Sanjeev Singal (Managing Director), Mr. Sanjay Dhir (Whole-time Director) |
Our journey and innovations Expanded portfolio and territory over 30 years; diversified into neurology and cytrics segments in 2023; WHO GMP certified for quality. |
Where we operate Primarily India with a comprehensive global network through collaboration with Zenlabs Pharmaceutical Inc., Canada. |
Top products or what we offer Over 600 branded pharmaceutical products including drugs for gastrointestinal disorders, anti-diabetics, anti-hypertensives, and nutraceuticals. |
Top brands - |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue largely dependent on pharmaceutical product sales, subject to market demand fluctuations. |
Our industry position Strong competitive position optimized through business model enhancements and portfolio reshaping in recent years. |
Financial highlights FY2025 revenue approximately Rs. 514 crore; net profit Rs. 2.7 crore; steady operational performance with prudent expenditures. |
Geographical revenue split Revenue primarily from Indian pharmaceutical markets; global network supports supply chain. |
Order book - |
Whats driving growth Diversification into neurology; expansion of branded product portfolio; collaboration with international partners; sustained demand for affordable medicines. |
Our future plans Continue portfolio diversification; enhance supply chain and sales capabilities; invest in employee talent and innovation culture. |
Our green promise Committed to ethical governance, employee well-being, and minimizing environmental impact. |
Our people and values Focus on transparent governance, human rights, employee safety, and inclusion. |
Key challenges ahead Market competition, regulatory compliance, and maintaining growth amid economic fluctuations. |
Interesting facts WHO GMP certification underpinning manufacturing quality; over 600 pharmaceutical products marketed. |
Risks and strategy Market risks managed via portfolio diversification; risk management policy established with ongoing oversight. |
